CC
GRCL

Cannell Capital’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Cannell Capital’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,299
Closed -$26.6K – 94
2023
Q1 		$26.6K Hold
14,299
– – 0.01% 82
2022
Q4 		$32.9K Hold
14,299
– – 0.01% 77
2022
Q3 		$46K Buy
14,299
+12,110
+553% +$39K 0.01% 69
2022
Q2 		$12K Buy
+2,189
New +$12K ﹤0.01% 71